![](https://sourceonhealth.wpenginepowered.com/wp-content/uploads/2019/04/SLIHCQ-title-1.png)
Kan. Stat. Ann. §§ 39-7,116 through 7,121g: Drug Utilization Review Program – Kansas
Status: EnactedYear Enacted: 1990
Year Amended: 2016
File: Download
The secretary of health and environment shall implement a drug utilization review program with the assistance of a medicaid drug utilization review board as provided in K.S.A. 39-7,119, and amendments thereto, to assure the appropriate utilization of drugs by patients receiving medical assistance under the medicaid program.
Key Issues:
Medicaid Pharmaceuticals
Provider Payment
Therapeutic Substitution
Benefit Design
PHARMACEUTICALS
Biosimilar or Generic Competition
PRICE AND QUALITY TRANSPARENCY
Utilization Review
Network Adequacy
Delivery Reform
HEALTHCARE SYSTEM REFORM
Cost-Sharing or Out-of-Pocket Costs
Prior Authorization
HEALTHCARE COSTS
Drug Formulary
Scope of Practice
Drug Pricing
Cost Containment
HEALTHCARE MARKETS
Provider Network
Return to Database Search
© 2018- The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.
Associated Litigation:
No items found